FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2049131130> ?p ?o ?g. }

• W2049131130 endingPage "192" @default.
• W2049131130 startingPage "188" @default.
• W2049131130 abstract "Objective: The objective of this study was to compare vasopressor requirements between African American (AA) patients and white patients in septic shock. Methods: This was a retrospective cohort review conducted over a 2-year period measuring total and mean dosage of various vasopressors used between two racial groups during the treatment of patients admitted with septic shock. The study included patients admitted to the intensive care unit with septic shock at an 805-bed tertiary, academic center. All septic shock patients were managed with vasopressors. Vasopressor selection, dosage, and duration were at the discretion of the treating physician. Total, mean, and duration of vasopressor dosing requirements were obtained for study participants. Comorbidities, prehospitalization antihypertensive medication requirements, intravenous fluids given during the septic shock phase, and source of infection were analyzed. Results: One hundred fifty-nine patients with septic shock were analyzed, of which 96 (60.4%) were AAs (P < 0.059). African Americans had higher rates of end-stage renal disease and hypertension compared with whites, 85.7% vs. 14.3% (P < 0.011; odds ratio [OR], 15.684) and 68.3% vs. 31.7% (P < 0.007; OR, 3.357), respectively. Norepinephrine (NE) was administered to 150 patients, 57.2% of which were AAs (P < 0.509). Thirteen patients received dopamine (5% AAs, P < 0.588), 40 patients received phenylephrine (15.7% AAs, P < 0.451), and five patients received epinephrine (1.9% AAs, P < 0.660). Comparing vasopressors between races, only NE showed statistical significance via logistic regression modeling for the AA race in terms of total dosage (AAs 736.8 [SD, 897.3] μg vs. whites 370 [SD, 554.2] μg, P < 0.003), duration of vasopressor used (AAs 38.38 [SD, 34.75] h vs. whites 29.09 [SD, 27.11] h, P < 0.037), and mean dosage (AAs 21.08 [SD, 22.23] μg/h vs. whites 12.37 [SD, 13.86] μg/h, P < 0.01). Mortality between groups was not significant. Logistic regression identified discrepancy of the mean dose NE in AAs compared with whites, with OR of 1.043 (P = 0.01). Conclusions: African American patients with septic shock were treated with higher doses of NE and required longer duration of NE administration compared with white patients." @default.
• W2049131130 created "2016-06-24" @default.
• W2049131130 creator A5000500674 @default.
• W2049131130 creator A5001386375 @default.
• W2049131130 creator A5003554217 @default.
• W2049131130 creator A5017189558 @default.
• W2049131130 creator A5030199126 @default.
• W2049131130 creator A5052153708 @default.
• W2049131130 creator A5055788672 @default.
• W2049131130 creator A5058128484 @default.
• W2049131130 creator A5086279999 @default.
• W2049131130 date "2014-03-01" @default.
• W2049131130 modified "2023-10-16" @default.
• W2049131130 title "Racial Differences in Vasopressor Requirements for Septic Shock" @default.
• W2049131130 cites W1519792525 @default.
• W2049131130 cites W1930087082 @default.
• W2049131130 cites W1973379750 @default.
• W2049131130 cites W1984304831 @default.
• W2049131130 cites W1988199204 @default.
• W2049131130 cites W1991840798 @default.
• W2049131130 cites W1993440563 @default.
• W2049131130 cites W1997471839 @default.
• W2049131130 cites W2029900767 @default.
• W2049131130 cites W2059261098 @default.
• W2049131130 cites W2074693408 @default.
• W2049131130 cites W2075905365 @default.
• W2049131130 cites W2081034252 @default.
• W2049131130 cites W2087203965 @default.
• W2049131130 cites W2108885025 @default.
• W2049131130 cites W2145422631 @default.
• W2049131130 cites W2145577370 @default.
• W2049131130 cites W2157888779 @default.
• W2049131130 cites W2160691650 @default.
• W2049131130 cites W2162590593 @default.
• W2049131130 cites W3023757607 @default.
• W2049131130 doi "https://doi.org/10.1097/shk.0000000000000103" @default.
• W2049131130 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24365885" @default.
• W2049131130 hasPublicationYear "2014" @default.
• W2049131130 type Work @default.
• W2049131130 sameAs 2049131130 @default.
• W2049131130 citedByCount "9" @default.
• W2049131130 countsByYear W20491311302014 @default.
• W2049131130 countsByYear W20491311302015 @default.
• W2049131130 countsByYear W20491311302018 @default.
• W2049131130 countsByYear W20491311302021 @default.
• W2049131130 countsByYear W20491311302022 @default.
• W2049131130 countsByYear W20491311302023 @default.
• W2049131130 crossrefType "journal-article" @default.
• W2049131130 hasAuthorship W2049131130A5000500674 @default.
• W2049131130 hasAuthorship W2049131130A5001386375 @default.
• W2049131130 hasAuthorship W2049131130A5003554217 @default.
• W2049131130 hasAuthorship W2049131130A5017189558 @default.
• W2049131130 hasAuthorship W2049131130A5030199126 @default.
• W2049131130 hasAuthorship W2049131130A5052153708 @default.
• W2049131130 hasAuthorship W2049131130A5055788672 @default.
• W2049131130 hasAuthorship W2049131130A5058128484 @default.
• W2049131130 hasAuthorship W2049131130A5086279999 @default.
• W2049131130 hasBestOaLocation W20491311301 @default.
• W2049131130 hasConcept C126322002 @default.
• W2049131130 hasConcept C156957248 @default.
• W2049131130 hasConcept C167135981 @default.
• W2049131130 hasConcept C2776376669 @default.
• W2049131130 hasConcept C2777288759 @default.
• W2049131130 hasConcept C2777628635 @default.
• W2049131130 hasConcept C2778384902 @default.
• W2049131130 hasConcept C2778514916 @default.
• W2049131130 hasConcept C2781300812 @default.
• W2049131130 hasConcept C2909186138 @default.
• W2049131130 hasConcept C42219234 @default.
• W2049131130 hasConcept C513476851 @default.
• W2049131130 hasConcept C71924100 @default.
• W2049131130 hasConcept C84393581 @default.
• W2049131130 hasConceptScore W2049131130C126322002 @default.
• W2049131130 hasConceptScore W2049131130C156957248 @default.
• W2049131130 hasConceptScore W2049131130C167135981 @default.
• W2049131130 hasConceptScore W2049131130C2776376669 @default.
• W2049131130 hasConceptScore W2049131130C2777288759 @default.
• W2049131130 hasConceptScore W2049131130C2777628635 @default.
• W2049131130 hasConceptScore W2049131130C2778384902 @default.
• W2049131130 hasConceptScore W2049131130C2778514916 @default.
• W2049131130 hasConceptScore W2049131130C2781300812 @default.
• W2049131130 hasConceptScore W2049131130C2909186138 @default.
• W2049131130 hasConceptScore W2049131130C42219234 @default.
• W2049131130 hasConceptScore W2049131130C513476851 @default.
• W2049131130 hasConceptScore W2049131130C71924100 @default.
• W2049131130 hasConceptScore W2049131130C84393581 @default.
• W2049131130 hasIssue "3" @default.
• W2049131130 hasLocation W20491311301 @default.
• W2049131130 hasLocation W20491311302 @default.
• W2049131130 hasLocation W20491311303 @default.
• W2049131130 hasOpenAccess W2049131130 @default.
• W2049131130 hasPrimaryLocation W20491311301 @default.
• W2049131130 hasRelatedWork W1980752706 @default.
• W2049131130 hasRelatedWork W2108153775 @default.
• W2049131130 hasRelatedWork W2174753756 @default.
• W2049131130 hasRelatedWork W2316383680 @default.
• W2049131130 hasRelatedWork W2337768265 @default.
• W2049131130 hasRelatedWork W2555296288 @default.

• next